The cofounder and chief executive officer of Verve Therapeutics discussed the company’s pipeline.
Sekar Kethiresan, MD
Advertisement
Articles by Sekar Kethiresan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
2
Lessons Learned From the Past 25 Years of Cell and Gene Therapy Research
3
FDA Activity Recap: November 2025 Features SMA Approval, Boxed Warning for Elevidys, and More
4
Key Unknowns Remain in Cell and Gene Therapy
5
